Srolo Bzhtang, a traditional Tibetan medicine formula, inhibits cigarette smoke induced airway inflammation and muc5ac hypersecretion via suppressing IL-13/STAT6 signaling pathway in rats
Bibliographic Data
| ID | 14745358 |
|---|---|
| Authors | Linde Jing (Qinghai University), Shanshan Su (0000-0002-3877-7435, Qinghai University), Dejun Zhang (0000-0001-9129-534X, Qinghai University), Zhanqiang Li (0000-0002-6482-3255, Qinghai University, corresponding author), Dianxiang Lu (0000-0001-5677-2833, Qinghai University, corresponding author), Rili Ge, Ri‐Li Ge (0000-0003-0615-7060, Qinghai University, corresponding author) |
| Year | 2019 |
| Volume | 235 |
| Pages | 424-434 |
| Publication date | 2019-05-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2019.02.006 |
| PMID | 30731182 |
| OpenAlex | W2911349844 |
| Language | EN |
| Citations received | 4 |
| References cited | 44 |
Biology · Bronchitis · Bronchoalveolar lavage · Chronic bronchitis · COPD · Dexamethasone · H&E stain · Immunohistochemistry · Inflammation · Lung · Mucus · Pathology · Traditional medicine · Western blot · Asthma and respiratory diseases · Chemistry · Herbal Medicine Research Studies · Medicinal Plants and Bioactive Compounds · Medicine · Biochemistry · Immunology · Internal Medicine · Pharmacology
Srolo Bzhtang reduces inflammation and vascular remodeling via suppression of the Mapk/NF-κB signaling pathway in rats with pulmonary arterial hypertension
Chinese herbal formula Regan Saibisitan alleviates airway inflammation of chronic bronchitis via inhibiting the JAK2/STAT3 pathway
Effects of Tibetan medicine Longdan zhike tablet on chronic obstructive pulmonary disease through Mapk pathway
Screening of bioactive ingredients of Tsantan Sumtang in ameliorating H9c2 cells injury
| Unique citing works | 4 |
|---|---|
| Citations per year | 1 |
| Citation span | 2022 - 2025 (4) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 4 |